Engineered proteins for treatment of pancreatitis

We are developing a treatment for pancreatitis based on a protease inhibitor with enhanced pharmacokinetics and tissue distribution. Initial experiments indicate that an engineered protein lead compound can be inexpensively produced at high levels, is active in vitro, and is active in initial animal tests.